文献速递造血干细胞移植与细胞治疗白血病

急性白血病异基因干细胞移植后预防性供者淋巴细胞输注——EBMT急性白血病工作组的一项配对分析

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.
PubMed 文献 · Br J Haematol · 2018-11-22

该注册库配对分析评估了预防性供者淋巴细胞输注(proDLI)在急性白血病异基因移植后预防复发中的疗效,共匹配89对患者(中位随访6.9年)。全队列未见差异,但在高危急性髓系白血病(AML)患者中,proDLI组总生存优于对照组(69.8% vs 40.2%,P=0.027)。proDLI疗效中等,但可能改善高危AML患者的结局。

要点

  • 全队列中预防性供者淋巴细胞输注与对照组相比未观察到差异。
  • 高危AML患者接受proDLI后总生存优于对照组(69.8% vs 40.2%,P=0.027)。
  • proDLI疗效中等,但可能改善高危AML患者的结局。

核心结论

  • 预防性供者淋巴细胞输注疗效中等,但可能改善高危急性髓系白血病患者的结局。

研究设计与样本

  • 基于注册库的配对分析,评估完全缓解期接受预防性供者淋巴细胞输注的成人患者与对照组的疗效。
  • 按年龄、诊断、细胞遗传学、分期、供者、性别、预处理和T细胞去除进行配对,共识别89对患者,中位随访6.9年。

主要发现

  • 全队列中未观察到差异。
  • 高危急性髓系白血病(不良细胞遗传学和/或移植时超过第一次完全缓解)患者中,proDLI组总生存为69.8%,对照组为40.2%(P=0.027)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Strategies for relapse prevention after allogeneic transplantation in acute leukaemia are warranted. A registry-based matched-pair analysis evaluated the efficacy of prophylactic donor lymphocyte infusion (proDLI). Adults receiving proDLI in complete remission (CR) and controls were pair-matched for age, diagnosis, cytogenetics, stage, donor, gender, conditioning and T-cell depletion. Eighty-nine pairs were identified (median follow-up: 6.9 years). Within the entire cohort, no difference was observed. However, among patients with high-risk acute myeloid leukaemia (AML) (unfavourable cytogenetics and/or transplanted beyond first CR), proDLI recipients had improved overall survival (69.8% vs. 40.2% in controls, P = 0.027). ProDLI has moderate efficacy, but can contribute to improved outcome in high-risk AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Schmid C, Labopin M, Schaap N, et al. Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT. Br J Haematol. 2018. PMID: 30467839. doi:10.1111/bjh.15691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。